{"id":396825,"date":"2025-03-22T13:55:00","date_gmt":"2025-03-22T12:55:00","guid":{"rendered":"https:\/\/medizinonline.com\/la-adicion-de-tafasitamab-mejora-significativamente-la-supervivencia-libre-de-progresion\/"},"modified":"2025-03-21T21:55:41","modified_gmt":"2025-03-21T20:55:41","slug":"la-adicion-de-tafasitamab-mejora-significativamente-la-supervivencia-libre-de-progresion","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/es\/la-adicion-de-tafasitamab-mejora-significativamente-la-supervivencia-libre-de-progresion\/","title":{"rendered":"La adici\u00f3n de tafasitamab mejora significativamente la supervivencia libre de progresi\u00f3n"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Los resultados del ensayo de fase 3 (inMIND) indican una nueva opci\u00f3n de tratamiento para el linfoma folicular recidivante o resistente al tratamiento: La adici\u00f3n de tafasitamab a la lenalidomida y el rituximab prolong\u00f3 significativamente la supervivencia libre de progresi\u00f3n.<\/strong><\/p>\n\n\n\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fla-adicion-de-tafasitamab-mejora-significativamente-la-supervivencia-libre-de-progresion%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Los resultados del ensayo de fase 3 (inMIND) indican una nueva opci\u00f3n de tratamiento para el linfoma folicular recidivante o resistente al tratamiento: La adici\u00f3n de tafasitamab a la lenalidomida&#8230;&hellip;... <\/p>\n<div class=\"pmpro\"><div class=\"pmpro_card pmpro_content_message\"><div class=\"pmpro_card_content\">Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich <br \/><a href=\"https:\/\/medizinonline.com\/es\/mi-cuenta\/paquetes\/\">Jetzt beitreten<\/a><\/div><div class=\"pmpro_card_actions pmpro_font-medium\">\u00bfYa eres miembro? <a href=\"https:\/\/medizinonline.com\/es\/conectarse\/?redirect_to=https%3A%2F%2Fmedizinonline.com%2Fes%2Fla-adicion-de-tafasitamab-mejora-significativamente-la-supervivencia-libre-de-progresion%2F\">Accede aqu\u00ed<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":396827,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Linfoma folicular","footnotes":""},"category":[11552,11483,11475,11336],"tags":[25751,81780,54955,81879],"powerkit_post_featured":[],"class_list":["post-396825","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-es","category-el-congreso-informa","category-estudios","category-oncologia","tag-ash-es","tag-ash-2024-es","tag-linfoma-folicular-es","tag-tafasitamab-es","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-06-20 02:23:25","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"es_ES","wpml_translations":[],"_links":{"self":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/396825","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/comments?post=396825"}],"version-history":[{"count":2,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/396825\/revisions"}],"predecessor-version":[{"id":397693,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/posts\/396825\/revisions\/397693"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media\/396827"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/media?parent=396825"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/category?post=396825"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/tags?post=396825"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/es\/wp-json\/wp\/v2\/powerkit_post_featured?post=396825"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}